Home/Filings/4/0001415889-22-001055
4//SEC Filing

Bohen Sean 4

Accession 0001415889-22-001055

CIK 0001750284other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 7:02 PM ET

Size

5.4 KB

Accession

0001415889-22-001055

Insider Transaction Report

Form 4
Period: 2022-02-01
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-01+812,250812,250 total
    Exercise: $7.02Exp: 2032-01-31Common Stock (812,250 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001831218

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:02 PM ET
Size
5.4 KB